Posts Tagged ‘IPXL’

Bullish Options In Play At Impax Laboratories

 

Today’s tickers: IPXL, YUM & APOL

IPXL - Impax Laboratories, Inc. – Upside call options are active on specialty pharmaceutical company, Impax Laboratories, Inc., this morning, with shares in the name up better than 1.5% on the day at $21.89 as of 11:20 a.m. ET. Shares in Impax, which last week announced it has resumed shipping pain medication, Oxymorphone Hydrochloride Extended Release Tablets, through its generics division have increased 7% since the start of the New Year. Traders betting the stock has more room to run in the near term snapped up February expiry calls this morning. The Feb. $22.5 strike calls are most active, with upwards of 5,900 contracts in play versus open interest of 851 contracts. It looks like most of the calls were purchased for an average premium of $1.32 apiece, thus positioning buyers to profit at expiration next month should Impax shares rally another 9% to exceed the average breakeven price of $23.82. Bullish traders also looked to the Feb. $25 strike where some 690 call options were purchased in the early going at an average premium of $0.54 each. The drug maker reports fourth-quarter earnings ahead of the opening bell on February 26th, more than one week after the February options expiration.

YUM - Yum! Brands, Inc. – The restaurant operator’s shares kicked off Wednesday’s trading session in recovery mode, rising modestly following a more than 4% decline in the price of the underlying on Tuesday. The rally has so far proven to be short-lived, however, with shares in the name now down 0.80% at $64.19 as of 12:00 p.m. ET in New York. A three-legged bearish options spread initiated on the operator of KFC, Pizza Hut and Taco Bell today looks for shares in Yum! Brands to potentially drop to the lowest level since October 2011 by this time next year. It looks like one strategist sold 2,500 calls at the Jan. 2014 $70 strike in order to offset the cost of buying a 2,500-lot Jan. 2014 $50/$62.5 put spread. The spread traded flat and positions the options player to…
continue reading


Tags: , ,




Corinthian Colleges Call Options In Demand After Earnings Beat

 

Today’s tickers: COCO, IPXL & BEN

COCO - Corinthian Colleges, Inc. – Shares in the for-profit provider of post-secondary, career-oriented education programs increased as much as 44.2% to an intraday high of $4.37 at the start of the session after the Company’s full-year 2012 earnings forecast of $0.30 a share beat average analyst expectations of $0.24 a share. The stock is off earlier post-earnings report highs, but continues to trade up 30.0% on the day at $3.93 as of 12:30 p.m. in New York. Options traders positioning for shares in Corinthian Colleges to extend gains in the near term purchased more than 2,800 calls at the Feb. $4.0 strike for an average premium of $0.27 apiece. Investors long the calls may profit at February expiration in the event that COCO’s shares rally 8.7% over the current price of $3.93 to exceed the average breakeven point at $4.27. Bullish call buying spread to the Mar. $4.0 strike, where around 375 contracts were purchased for an average premium of $0.38 each.

IPXL - Impax Laboratories, Inc. – The specialty pharmaceutical company popped up on our ‘hot by options volume’ market scanner this morning after one strategist took a large stake in front-month calls. Shares in Impax Laboratories surged 10.85% to $20.93 today on news Impax Pharmaceuticals, the branded drugs unit of Hayward, California-based Impax Laboratories, Inc., licensed exclusive U.S. commercial rights to Zomig® from AstraZeneca. Zomig is a drug used to treat acute migraine headaches with or without aura. The options trader responsible for the single largest transaction in IPXL options today appears to have purchased 2,000 calls at the Feb. $20 strike for an average premium of $0.80 per contract. The size of the position is noteworthy relative to overall open interest of…
continue reading


Tags: , ,




 
 
 

Zero Hedge

Philly Fed Unexpectedly Soars To Second Highest Since Financial Crisis

Courtesy of ZeroHedge View original post here.

Anyone expecting the coronavirus pandemic to hit regional Fed surveys following the recent plunge in the Chicago PMI was in for a disappointment this week, when first the NY Fed's Empire State mfg survey unexpectedly printed at the highest since mid-2018, and then moments ago the Philly Fed blew it out of the ballpark with a massive surge in its business outlook survey, where the current general activity rose nearly 20 points this month to 36.7, smashing expectations of a drop from 17.0 to 11.0, and the highest index reading since February 2017. More importantly, this was the se...



more from Tyler

The Technical Traders

Is The Technology Sector Setting Up For A Crash? Part IV

Courtesy of Technical Traders

As we continue to get more and more information related to the Coronavirus spreading across Asia and Europe, the one thing we really must consider is the longer-term possibility that major global economies may contract in some manner as the Chinese economy is currently doing.  The news suggests over 700+ million people in China are quarantined.  This is a staggering number of people – nearly double the total population of the entire United States.

If the numbers presented by the Chinese are accurate, the Coronavirus has a very high infection rate, yet a moderately small mortality rate (2~3%).  Still, if this virus continues to spread throughout the world and infects m...



more from Tech. Traders

Phil's Favorites

Why Trump's post-impeachment actions are about vengeance, not retribution

 

Why Trump's post-impeachment actions are about vengeance, not retribution

President Trump fired Army Lt. Col. Alexander Vindman for testifying in his impeachment trial. AP Photo/Susan Walsh, File

Courtesy of Austin Sarat, Amherst College

Since the end of his Senate impeachment trial, President Donald Trump has carried out a concerted campaign against ...



more from Ilene

Biotech & Health

Deep learning AI discovers surprising new antibiotics

 

Deep learning AI discovers surprising new antibiotics

A colored electron microscope image of MRSA. NIH - NIAID/flickr, CC BY

Courtesy of Sriram Chandrasekaran, University of Michigan

Imagine you’re a fossil hunter. You spend months in the heat of Arizona digging up bones only to find that what you’ve uncovered is from a previously discovered dinosaur.

That’s how the search for antibiotics has panned out recently. The relatively few antibiotic hunters out there ...



more from Biotech

Kimble Charting Solutions

King Dollar Going To Lose Strength Here? Gold & Silver Hope So!!!

Courtesy of Chris Kimble

Is King$ and the Euro facing important breakout/breakdown tests at the same time? It looks like it in this chart!

The US$ trend remains up, as it has created a series of higher lows since the start of 2018. The opposite can be said for the Euro, as it has created a series of lower highs since early 2018.

The US$ is currently testing the top of its 18-month rising channel, as the Euro is testing the bottom of its falling channel.

What King$ and...



more from Kimble C.S.

Insider Scoop

The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study

Courtesy of Benzinga

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peaks

(Biotech Stocks Hitting 52-week highs on Feb. 19)

  • Adverum Biotechnologies Inc (NASDAQ: ADVM)
  • Akebia Therapeutics Inc (NASDAQ: AKBA)
  • Ana...


http://www.insidercow.com/ more from Insider

Digital Currencies

Altcoin season 2.0: why bitcoin has been outgunned by crypto rivals since new year

 

Altcoin season 2.0: why bitcoin has been outgunned by crypto rivals since new year

‘We have you surrounded!’ Wit Olszewski

Courtesy of Gavin Brown, Manchester Metropolitan University and Richard Whittle, Manchester Metropolitan University

When bitcoin was trading at the dizzying heights of almost US$2...



more from Bitcoin

ValueWalk

What US companies are saying about coronavirus impact

By Aman Jain. Originally published at ValueWalk.

With the coronavirus outbreak coinciding with the U.S. earnings seasons, it is only normal to expect companies to talk about this deadly virus in their earnings conference calls. In fact, many major U.S. companies not only talked about coronavirus, but also warned about its potential impact on their financial numbers.

Q4 2019 hedge fund letters, conferences and more

Coronavirus impact: many US companies unclear

According to ...



more from ValueWalk

Chart School

RTT browsing latest..

Courtesy of Read the Ticker

Please review a collection of WWW browsing results. The information here is delayed by a few months, members get the most recent content.



Date Found: Tuesday, 01 October 2019, 02:18:22 AM

Click for popup. Clear your browser cache if image is not showing.


Comment: Wall of worry, or cliff of despair!



Date Found: Tuesday, 01 October 2019, 06:54:30 AM

Click for popup. Clear your browser cache if image is not showing.


Comment: Interesting.. Hitler good for the German DAX when he was winning! They believed .. until th...



more from Chart School

Members' Corner

How to Stop Bill Barr

 

How to Stop Bill Barr

We must remove this cancer on our democracy.

Courtesy of Greg Olear, at PREVAIL, author of Dirty Rubles: An Introduction to Trump/Russia

...



more from Our Members

Lee's Free Thinking

Why Blaming the Repo Market is Like Blaming the Australian Bush Fires

 

Why Blaming the Repo Market is Like Blaming the Australian Bush Fires

Courtesy of  

The repo market problem isn’t the problem. It’s a sideshow, a diversion, and a joke. It’s a symptom of the problem.

Today, I got a note from Liquidity Trader subscriber David, a professional investor, and it got me to thinking. Here’s what David wrote:

Lee,

The ‘experts’ I hear from keep saying that once 300B more in reserves have ...



more from Lee

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. Contact Ilene to learn about our affiliate and content sharing programs.